Avicel® microcrystalline cellulose (MCC) is Pharma Solutions’ leading binder and compression aid for pharmaceutical developments. MCC is a pure, partially depolymerized cellulose developed via acid hydrolysis of specialty wood pulp.

With the availability of different grades, our Avicel® portfolio delivers broad versatility for a wide range of applications; making it an indispensable formulation tool to the pharmaceutical industry. For 60+ years, the excipient has been at the forefront of tablet binding and helped to overcome some of the toughest challenges – delivering superior tablet strength and performance, improved powder blending, increased batch size, reduced API degradation and more.